SIGN UP FOR THE LIFEMAG BRIEF

Receive our top articles each week direct to your inbox

In the News

CRISPR gene editing to be tested on people by 2017, says Editas

Published on 6th Nov 2015

Published on 6th November 2015

Editas, a biotechnology startup based in Boston, have announced that they will soon begin clinical trials on humans using CRISPR to treat a rare form of eye disease called Laber congenital amaurosis, which affects the light-receiving cells of the retina. 

Read more @ MIT Technology Review